Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. (DMIIR) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Drugs Made In America Acquisition II Corp..

DMIIR●NASDAQ
Financial ServicesFinancial - Conglomerates
$0.08
$0.00(0.00%)
U.S. Market opens in 6h 28m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DMIIR Technical Analysis Summary

Drugs Made In America Acquisition II Corp. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 48.87)
Trend Strength:Weak (ADX: 14.21)
Volatility:High (ATR: 0.01)
Support/Resistance:$0.07 – $0.10 (Bollinger Bands)

Technical conditions suggest Drugs Made In America Acquisition II Corp. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 48.87

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 54.44

Neutral
Mid-range signal with no clear trend.

Williams %R: -68.35

Bearish
Sellers maintain momentum below neutral.

Rate of Change (ROC): 12.19

Strongly Bullish
Strong upside momentum.

Takeaway:Drugs Made In America Acquisition II Corp. shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: 0.00

Neutral
Neutral, momentum shows no clear direction.

ADX: 14.21

Weak
Weak trend, market trading sideways.

ATR (14): 0.01

Low
Low volatility, stable price action.

CCI (14): -19.81

Neutral
Neutral, no strong directional signal.

Takeaway:Drugs Made In America Acquisition II Corp. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$0.10
Middle Band (SMA 20)
$0.08
Lower Band
$0.07
Current Position
Within Bands

Takeaway:Drugs Made In America Acquisition II Corp. trades around the middle band, reflecting balanced price action.

Keltner Channels
Upper Channel
$0.10
Middle Line (EMA 20)
$0.08
Lower Channel
$0.06
Squeeze Status
Squeeze On

Takeaway:Drugs Made In America Acquisition II Corp. trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume-91.38K
Money Flow Index74.07Bullish, inflows support continued momentum.
Relative Vigor Index45.91Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:DMIIR shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Drugs Made In America Acquisition II Corp., here are the key trading signals and recommendations:

Bullish Signals

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Drugs Made In America Acquisition II Corp. shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.

Technical Analysis FAQ